Each year more than 5 million people take the drugs Ozempic, Wegovy or Mounjaro for treatment of type 2 diabetes or to trigger weight loss. In fact, their use has grown over 2,000% since 2019.
Unfortunately, new reports show many of these patients have developed a severe condition called gastroparesis, or stomach paralysis.
This chronic gastrointestinal disorder affects the nerves and muscles in the stomach, and can last for years after patients stop taking the medications.
Gastroparesis can result in a number of side effects, including:
In many cases, patients must undergo stomach surgery to improve emptying and digestion.
Experts from the National Institutes of Health, American Society of Anesthesiologists and FDA have all noted cases of gastroparesis among people taking drugs like Ozempic, Wegovy and Mounjaro.
Although the makers of these drugs have known about the risks of stomach paralysis for years, they failed to warn users and continue to downplay the dangers.
Latest Information on the Ozempic Litigation
No. The first individual lawsuits for victims of semaglutide and terzepatide stomach paralysis were filed in August of 2023 and lawyers expect thousands of patients will come forward to file similar claims.
In order to handle the volume of cases in the most efficient manner possible, the Judicial Panel for Multidistrict Litigation often consolidates lawsuits for similar injuries and damages into specific federal MDL courts.
Instead of creating a single class action lawsuit for Ozempic injuries, the MDL courts allow those affected to band their individual cases together in a special court to seek damages against the company.
This multidistrict litigation court (MDL) process is actually more beneficial for consumers than a class action lawsuit. In a class action lawsuit, one group of lawyers often gathers together class participants who must share whatever is awarded. However, the individual participants in a MDL are able to select their own lawyer, exercise more control over their case and whether it settles, and reap higher award amounts for their separate lawsuit.
With Ozempic, Wegovy and Mounjaro gastroparesis lawsuits growing quickly, lawyers will likely file a petition to consolidate the cases with the JPML board in the coming weeks.
DrugNews works only with lawyers that are integrally involved in defective drug MDL litigation or are active on the influential MDL Plaintiff Steering Committees.
If you or a loved one have been diagnosed with gastroparesis or had to undergo stomach surgery after taking Ozempic, Wegovy or Mounjaro, it’s important to have your case examined by a legal expert to see if you have the right to recover damages.
Our qualified prescription drug injury lawyers will fully investigate your case, reviewing medical records, safety warnings and recent studies that your doctor may not normally discuss.
Most states allow you several years to file a lawsuit after you suffer an injury or discover it may be linked to a dangerous product. However, you should begin the process as early as possible to make sure your lawyer has time to get necessary records and prepare your case.
DrugNews works only with attorneys and law firms that have successfully handled tens of thousands of lawsuits involving injury or death from drugs and medical devices. And, we can connect you directly to a lawyer or patient advocate today, so you’ll be able to decide if you want to proceed.
We make it easy to get help, find out if you qualify, and quickly file a claim. Our service is offered at no cost to you, and you won’t pay anything to your attorney unless you receive an award. Also, our qualified lawyers can handle most aspects of your case without you ever having to leave your home.
For more information, or to learn about your options - call, chat or email us today.